Multi-omics analysis and in vitro experiments identified SMARCA2 as a tumor suppressor gene with decreased expression in lung cancer, showing that its inactivation can be epigenetically driven by promoter hypermethylation [13]. This evidence concerns the gene SMARCA2 and lung cancer.